Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success

Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success

Source: 
Forbes
snippet: 

Johnson & Johnson and Apple recently launched a first-of-its-kind randomized virtual clinical trial and is already enrolling patients dramatically faster than standard studies. The Heartline trial is designed to explore if its heart healthy app, paired with the Apple Watch’s irregular rhythm notification (IRN) and electrocardiogram (ECG) apps, can help reduce the risk of stroke.